期刊文献+

慢性肾功能衰竭患者血管内皮生长因子测定及意义 被引量:1

The assay for vascular endothelial growth factor in patients with chronic renal failure and its significance
下载PDF
导出
摘要 目的 探讨慢性肾功能衰竭患者血、尿中血管内皮生长因子 (VEGF)的作用及其临床意义。方法 采用ELISA方法测定 31例慢性肾功能衰竭患者 (其中失代偿期患者 15例 ,肾功能衰竭期患者 16例 )和 15例正常人的血、尿中的VEGF水平。结果 不同阶段慢性肾功能衰竭患者血、尿液中的VEGF水平均明显高于对照组P<0 .0 0 1,P <0 .0 1。在肾功能衰竭期 ,血、尿液中的VEGF水平高于失代偿期P <0 .0 1,P <0 .0 0 1。尿液中的VEGF与肾小球滤过率 (GFR)呈负相关 ,与血肌酐 (Scr)和尿素氮 (BUN)呈正相关。结论 慢性肾功能衰竭患者血、尿液中的VEGF水平增高 ,可能与肾小球毛细血管损伤的修复增强 ,保护和维持肾功能有关。肾功能的损害越重 ,尿液中的VEGF排泌越多 ,VEGF可作为反映肾功能的一个独特标志。 Objective To explore the roles of vascular endothelial growth factor(VEGF) in the pathogenesis of chronic renal failure (CRF) and to evaluate the clinical value.Methods The serum and urinary levels of VEGF were examined by ELISA method from 31 patients with CRF (15 cases in the decompensated stage of renal dysfunction,and 16 cases in the end stage of renal dysfunction),as well as 15 health controls were examind.Results In the patients with CRF in different stages,the serum and urinary levels of VEGF were significantly higher than in the healty subjects.The serum and urinary levels of VEGF in the ens stage of renal dysfunction were higher than those in the decompensated stage of renal dysfunction.In additin,negative correlation was observed between the urinary level of VEGF and glomerular filtration rate (GFR).The urinary level of VEGF was positive correlated with serum creatinine(Scr) and blood urea nitrgen(BUN).Conclusions The serum and urinary levels of VEGF in patients with CRF were increased.The may have relationship with process of the repair of injured glomerular capillaries,protecting and maintaining the renal function.The more lesions the renal function are,the more excretion VEGF are.VEGF may be an unique marker of renal function.
出处 《北京医学》 CAS 北大核心 2002年第3期189-191,共3页 Beijing Medical Journal
关键词 慢性肾功能衰竭 血管内皮生长因子 肾小球滤过率 Chronic renal failure Vascular endothelial growth factor Glomerular filtration rate
  • 相关文献

参考文献11

  • 1[1]Leung DW,Cachiance G,Kuang WJ,et al.Vascular endothelial growth factor is a secreat angiogenic mitogen.Science,1989,246:1306~1309. 被引量:1
  • 2[2]Hariawala MD,Horowits JR,Esakof D,et al.VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts.J Surge Res,1996,63:77~82. 被引量:1
  • 3[3]Hayashi T,Abe K,Itoyama Y.Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient is chemia.J Cerbe Blood Flow Metab,1998,18:887~895. 被引量:1
  • 4[4]Masuda,Y,Shimizu ,Ishiwata T,et al.Vascular endothelial growth factor enhances glomerular capillary repair and accelerated resolution of experimentally induced glomerulonenephritis.Am J Patho,2001,159:599~608. 被引量:1
  • 5[5]Choi YJ,Chakrabort S,Nguyen C,et al.Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney:altered expression of vascular endothelial growth factor.Hun-Pathol,2000,31"1491~1497. 被引量:1
  • 6[6]Grone HJ,Simon M,Grone EF.Expressin of vascular endothelial growth factor in renal vascular disease and renal allografts.J-Pathol,1995,177:259~267. 被引量:1
  • 7[7]Kang DH,Hughes J,Mazzali M,et al.Imparied angiogenesis in the remnant kidney model:Ⅱ.Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.J Am Soc Nephrol,2001,12:1448~1457. 被引量:1
  • 8[8]Kitamoto Y,Tokunaga H,Miyamoto K,et al.VEGF is an essential molecule for glomerular endothelial cells and its excretion in urine might be a unique marker of glomerular injury.Rinsho Byori,2000,48:485~490. 被引量:1
  • 9[9]Losordo DW,Vale PR,Syme JF,et al.Gene therapy for myocardial angiogenesis:Initial clinical results with direct myocardial injectin of ph VEGF 165 as sole therapy for myocardial ischemia.Circulation,1998,98(25):2800~2804. 被引量:1
  • 10[10]Symes JF,Losordo DW,Vale PR,et al.Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease.Ann Thorac Surg,1999,68:836~837. 被引量:1

同被引文献6

  • 1Noguchi K, Yoshikawa N, Ito KS, et al, Activated mesangial cells produce vascular permeability factor in early-stage mesangial proliferative glomeralonephritis[J]. J Am Soc Nephrol,1998, (10):1815-1825. 被引量:1
  • 2Honkanen EO, Teppo AM, Gronhagen RC, et al. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis [J]. Kidney Int,2000,57(6) :2343-2349. 被引量:1
  • 3Ha IS, Urn EY, Jung HR, et al. Glueoeortieoid diminishes vascular endothelial growth factor and exacerbates proteinuria in rats with mesangial proliferative glomerulonephritis[J]. Am J Kidney Dis,2002,39(5) : 1001-1010. 被引量:1
  • 4Kang DH, Hughes J, Mazzali M, et al. Impaired angiogenesis inthe remnant kidney model:Ⅱ. Vascular endothelial growthfactor administration reduces renal fibrosis and stabilizes renal function[J]. J Am Soc Nephrol,2001,12(7) :1448-1451. 被引量:1
  • 5Kanellis J,Levidiotis V, Khong T, et al. A study of VEGF and its receptors in two rat models of proteinuria [J], Nephron Physiol,2004,96(1) :26-36. 被引量:1
  • 6Dunst J,BecKer A,Lautenschlager C,et al. Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF) [J]. Strahlenther Onkol, 2002,178(8):436-441. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部